RIA
MRNA icon

Realta Investment Advisors’s Moderna MRNA Stock Holding History

Realta Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,447
Closed -$222K – 841
2023
Q1 		$222K Buy
+1,447
New +$239K 0.05% 368
2022
Q1 		– Sell
-1,151
Closed -$292K – 448
2021
Q4 		$292K Buy
1,151
+256
+29% +$74.8K 0.06% 321
2021
Q3 		$344K Buy
895
+40
+5% +$14.8K 0.08% 271
2021
Q2 		$201K Buy
+855
New +$153K 0.05% 380
2020
Q2 		– Sell
-9,852
Closed -$295K – 352
2020
Q1 		$295K Buy
+9,852
New +$227K 0.13% 208

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Realta Investment Advisors's MRNA Position: Q2 2023 in Review

Realta Investment Advisors sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,447 shares — an estimated $222K sold.

Realta Investment Advisors first reported a position in MRNA in Q1 2020 and held it in 5 quarters. The position peaked at $344K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Realta Investment Advisors reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Realta Investment Advisors sold 1,447 Moderna shares in Q2 2023, an estimated $222K.
  • Realta Investment Advisors first reported a position in Moderna in Q1 2020 and held it in 5 quarters.
  • Realta Investment Advisors's Moderna position peaked at $344K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Realta Investment Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.